Sign in
BFRI Stock Price, Chart, Stats & News
Biofrontera Inc
Save
Biofrontera Inc (BFRI) does not currently pay a dividend.
14.21M
Market cap
–
Current P/E
13.64x
Forward P/E
BFRI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.76% |
Operating margin | -27.20% |
Pretax margin | -25.20% |
Net margin | -25.26% |
Effective tax rate | -0.24% |
ROA | -36.89% |
ROE | -1139.03% |
D/E | 0.59x |
Interest coverage ratio | -24.35x |
BFRI valuation
P/E | – |
P/S | 0.23x |
P/B | 0.91x |
P/CF | -0.71x |
P/FCF | -0.71x |
P/OCF | -0.71x |
PEG | -0.03x |
EV multiple | -0.94x |
About
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Similar securities
Based on sector and market capitalization
Report issue